Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

The altered pharmacokinetic properties of, e.g., aminoglycosides in cystic fibrosis patients have to be considered when pulmonary exacerbations are treated. Since reported data on ciprofloxacin, a fluorinated quinolone, are conflicting, we compared intravenous and oral administration in cystic fibro...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Christensson, B A, Nilsson-Ehle, I, Ljungberg, B, Lindblad, A, Malmborg, A S, Hjelte, L, Strandvik, B
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1992
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284363/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1489195/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.11.2512
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!